Next Treatments
Back to Eczema

BGB-45035

TypePill StagePhase 1 Latest updateJun 2, 2026Phase 1 study completed · Eczema target not confirmed

History

Earliest recorded event: Jun 20, 2024. This timeline shows events collected by Eczema Radar and may not include the treatment’s full history. Study details reflect the latest registry record available here.

  • Jun 2, 2026Phase 1 trial completed · Eczema target not confirmedA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases ClinicalTrials.gov NCT06342713
  • Jun 20, 2024Phase 1 trial started · Eczema target not confirmedA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases ClinicalTrials.gov NCT06342713

Sources

Trials